Itamar Medical Ltd. | Mutual Funds

Mutual Funds that own Itamar Medical Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Yelin Lapidot Menayatit
3,300,000
1.14%
0
0.28%
04/30/2018
Yelin Lapidot Yeter
3,070,000
1.07%
0
0.98%
04/30/2018
Dash Foreign Stocks
2,904,480
1.01%
217,597
2.19%
06/28/2018
Meitav Yeter
2,110,125
0.74%
444,106
2.52%
06/28/2018
Yelin Lapidot Memukeder Didivend
1,840,000
0.64%
0
0.36%
04/30/2018
Yelin Lapidot Gmisha Memukedet
1,670,000
0.57%
0
0.45%
06/28/2018
Meitav Shares
1,501,694
0.52%
0
2.39%
06/28/2018
1,035,545
0.36%
0
0.07%
06/28/2018
821,000
0.28%
0
0.18%
06/28/2018
More Maaser Gmisha
817,599
0.28%
-71,289
0.08%
05/31/2018

About Itamar Medical

View Profile
Address
9 Halamish Street
Caesarea HA 38900
Israel
Employees -
Website http://www.itamar-medical.com
Updated 07/08/2019
Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. The firm develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease.